Among 21 analysts covering McKesson Corporation (NYSE:MCK), 10 have Buy rating, 1 Sell and 10 Hold. Therefore 48% are positive. McKesson Corporation had 72 analyst reports since July 31, 2015 according to SRatingsIntel. The stock of McKesson Corporation (NYSE:MCK) has “Outperform” rating given on Tuesday, January 12 by RBC Capital Markets. The firm has “Neutral” rating given on Thursday, October 6 by UBS. As per Friday, October 28, the company rating was downgraded by Leerink Swann. Needham maintained the stock with “Buy” rating in Tuesday, October 24 report. S&P Research maintained the stock with “Buy” rating in Friday, July 31 report. Credit Suisse downgraded McKesson Corporation (NYSE:MCK) on Monday, December 18 to “Sell” rating. The company was maintained on Tuesday, October 27 by Mizuho. On Friday, July 28 the stock rating was upgraded by Jefferies to “Buy”. The rating was maintained by JP Morgan with “Overweight” on Tuesday, August 9. The rating was downgraded by Credit Suisse on Wednesday, November 23 to “Underperform”. See McKesson Corporation (NYSE:MCK) latest ratings:
18/12/2017 Broker: Credit Suisse Rating: Sell New Target: $130.0 Downgrade
04/12/2017 Broker: Deutsche Bank Rating: Buy New Target: $175 Initiates Coverage On
09/11/2017 Broker: Credit Suisse Rating: Sell New Target: $130.0 Maintain
01/11/2017 Broker: Needham Rating: Buy Old Target: $178.00 New Target: $173.00 Maintain
30/10/2017 Broker: Needham Rating: Buy New Target: $173.0 Maintain
26/10/2017 Broker: Robert W. Baird Rating: Buy New Target: $183.0 Maintain
24/10/2017 Broker: Mizuho Rating: Hold New Target: $168.0 Maintain
24/10/2017 Broker: Needham Rating: Buy New Target: $178.0 Maintain
18/10/2017 Broker: Jefferies Rating: Hold New Target: $165.0 Maintain
16/10/2017 Broker: Needham Rating: Buy New Target: $179.0 Maintain
Crown Holdings, Inc. (CCK) formed multiple top with $58.96 target or 5.00% above today’s $56.15 share price. Crown Holdings, Inc. (CCK) has $7.54B valuation. The stock decreased 0.18% or $0.1 during the last trading session, reaching $56.15. About 1.26 million shares traded or 34.65% up from the average. Crown Holdings, Inc. (NYSE:CCK) has risen 7.50% since December 23, 2016 and is uptrending. It has underperformed by 9.20% the S&P500.
Analysts await Crown Holdings, Inc. (NYSE:CCK) to report earnings on February, 1. They expect $0.79 EPS, up 11.27% or $0.08 from last year’s $0.71 per share. CCK’s profit will be $106.07 million for 17.77 P/E if the $0.79 EPS becomes a reality. After $1.41 actual EPS reported by Crown Holdings, Inc. for the previous quarter, Wall Street now forecasts -43.97% negative EPS growth.
Investors sentiment increased to 1.16 in Q3 2017. Its up 0.31, from 0.85 in 2017Q2. It increased, as 23 investors sold Crown Holdings, Inc. shares while 96 reduced holdings. 43 funds opened positions while 95 raised stakes. 119.77 million shares or 0.32% less from 120.15 million shares in 2017Q2 were reported. New York-based Quantbot Technology Lp has invested 0.09% in Crown Holdings, Inc. (NYSE:CCK). Tower Cap Ltd (Trc) invested in 8,747 shares. Stillwater Cap Advsrs Ltd Liability owns 4,964 shares for 0.08% of their portfolio. Fuller And Thaler Asset Management holds 0% or 900 shares in its portfolio. Korea owns 46,100 shares or 0.01% of their US portfolio. Bnp Paribas Arbitrage accumulated 0% or 14,498 shares. Globeflex Cap Lp holds 12 shares or 0% of its portfolio. Robeco Institutional Asset Bv has invested 0% in Crown Holdings, Inc. (NYSE:CCK). Hsbc Public Ltd Company reported 273,229 shares. Verition Fund Management Ltd reported 0.11% stake. C M Bidwell And Associates Ltd stated it has 180 shares. Deutsche Natl Bank Ag has 316,051 shares for 0.01% of their portfolio. First Quadrant Lp Ca has 0.55% invested in Crown Holdings, Inc. (NYSE:CCK). Geode Capital Mngmt Ltd Liability Com, Massachusetts-based fund reported 1.04M shares. State Board Of Administration Of Florida Retirement Systems holds 201,599 shares or 0.03% of its portfolio.
Among 15 analysts covering Crown Holdings (NYSE:CCK), 9 have Buy rating, 0 Sell and 6 Hold. Therefore 60% are positive. Crown Holdings had 43 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of Crown Holdings, Inc. (NYSE:CCK) earned “Buy” rating by TheStreet on Wednesday, July 22. Vertical Research downgraded Crown Holdings, Inc. (NYSE:CCK) on Monday, April 25 to “Hold” rating. The rating was maintained by RBC Capital Markets on Tuesday, August 22 with “Buy”. On Monday, August 28 the stock rating was maintained by Jefferies with “Buy”. The firm earned “Buy” rating on Monday, July 10 by RBC Capital Markets. Jefferies maintained the stock with “Buy” rating in Thursday, May 25 report. On Monday, October 23 the stock rating was maintained by RBC Capital Markets with “Buy”. Deutsche Bank maintained Crown Holdings, Inc. (NYSE:CCK) rating on Tuesday, July 18. Deutsche Bank has “Hold” rating and $61 target. The firm has “Neutral” rating given on Tuesday, September 15 by Bank of America. The firm has “Overweight” rating by Barclays Capital given on Friday, October 20.
The stock decreased 0.60% or $0.95 during the last trading session, reaching $158.44. About 1.25 million shares traded. McKesson Corporation (NYSE:MCK) has declined 15.45% since December 23, 2016 and is downtrending. It has underperformed by 32.15% the S&P500.
Since August 21, 2017, it had 0 buys, and 6 selling transactions for $121.83 million activity. $30.59M worth of McKesson Corporation (NYSE:MCK) was sold by HAMMERGREN JOHN H on Thursday, September 28. Lampert Erin M had sold 900 shares worth $140,089. JACOBS M CHRISTINE had sold 1,083 shares worth $157,500.
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company has market cap of $33.03 billion. The firm operates in two divisions, McKesson Distribution Solutions and McKesson Technology Solutions. It has a 7.5 P/E ratio. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community oncology and other specialty practices.
Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.07, from 0.95 in 2017Q2. It turned negative, as 65 investors sold McKesson Corporation shares while 296 reduced holdings. 72 funds opened positions while 246 raised stakes. 180.04 million shares or 2.23% more from 176.11 million shares in 2017Q2 were reported. Amica Pension Fund Board Of Trustees holds 0.33% of its portfolio in McKesson Corporation (NYSE:MCK) for 18,109 shares. 3,430 were reported by Malaga Cove Capital Ltd Liability. Coastline Trust owns 11,620 shares. Cibc Asset reported 0.02% of its portfolio in McKesson Corporation (NYSE:MCK). Sun Life holds 0.04% or 2,345 shares. Credit Agricole S A accumulated 265,272 shares or 0.14% of the stock. North Star Asset Mngmt Inc invested in 5,920 shares or 0.09% of the stock. Peapack Gladstone Financial Corp, New Jersey-based fund reported 6,415 shares. 1.79 million were reported by Jpmorgan Chase Comm. Blb&B Advsr Ltd Liability Corp has 0.06% invested in McKesson Corporation (NYSE:MCK) for 2,653 shares. Michigan-based Clarkston Capital Prtnrs Lc has invested 0.3% in McKesson Corporation (NYSE:MCK). Canada Pension Plan Board accumulated 0.13% or 410,617 shares. At Comml Bank reported 6,868 shares stake. Frontier Invest reported 0.26% stake. Zwj Investment Counsel reported 0.03% stake.